Werfen has expanded commercialization for the Gem Premier 7000 with iQM3 blood fuel testing system to Europe. The system has been out there in North America since 2024.
The Gem Premier 7000 is the primary and solely blood fuel testing system to combine hemolysis detection on the level of care, addressing essentially the most frequent preanalytical error in blood fuel testing, accounting for as much as 70% of all such errors, in accordance with Werfen.1
In simply 45 seconds, the Gem Premier 7000 detects hemolysis, whereas delivering a whole menu of outcomes, together with: pH, pCO2, pO2, sodium, potassium, chloride, ionized calcium, glucose, lactate, hematocrit, complete bilirubin and CO-oximetry (tHb, O2Hb, COHb, MetHb, HHb, sO2).
“As a breakthrough in blood fuel testing, the Gem Premier 7000 with iQM3 has seen great success in North America, the place it has been embraced by clinicians and honored with a number of prestigious awards,” stated Remo Tazzi, Vice President of Worldwide Advertising and marketing and Service at Werfen. “By increasing commercialization throughout Europe, this transformative answer will shine a gentle on the hidden drawback of hemolysis, and advance care for a lot of extra sufferers.”
Regardless of its prevalence all through completely different areas of the hospital, hemolysis is not seen in entire blood and might go unrecognized. Hemolysis happens when purple blood cell membranes rupture, inflicting mobile contents to leak into the surrounding fluid, which may elevate potassium outcomes as much as 152%.2 In samples impacted by hemolysis, low potassium ranges can seem regular and regular ranges can seem excessive. Penalties of in vitro hemolysis can embody inappropriate affected person administration, longer size of keep, and elevated prices, amongst others.3-7
The Gem Premier 7000 with iQM3 has acquired six main awards, underscoring its influence on diagnostic drugs:
- 2025 Edison Award—Silver Winner in Emergency and On-Website Well being Options The Edison Awards honor excellence in innovation, recognizing the Gem Premier 7000 for its pioneering integration of hemolysis detection and its potential to remodel point-of-care diagnostics.
- 2024 Medical Machine Community Excellence Awards (3):
- Innovation Award—For being the primary system to combine hemolysis detection, enhancing diagnostic accuracy.
- Analysis & Improvement Award—Honoring its superior options, together with the all-in-one Gem Pak cartridge and steady high quality administration.
- Product Launch Award—Celebrating its profitable US market introduction and its influence on effectivity and affected person care.
- 2024 R&D 100 Award This award acknowledges the Gem Premier 7000 as one of many 100 most technologically important new merchandise and applied sciences launched in 2024. Highlighting groundbreaking developments throughout varied fields, this award is a mark of excellence within the scientific and technological group.
- 2025 Premier Inc. Provider Innovation Celebration Award Introduced by considered one of North America’s largest built-in supply networks, this award acknowledges the Gem Premier 7000 for its lab high quality hemolysis detection on the level of care and its contribution to supporting correct outcomes and streamlined workflows.
Werfen Unveils Hemostasis Testing Methods
Werfen will unveil the following era of market-leading ACL Prime testing techniques on the ADLM Annual Assembly 2025, reinforcing the Firm’s dedication to innovation in Specialised Diagnostics. Constructing upon the corporate’s established legacy of high quality and innovation in Hemostasis testing, ACL Prime Household 70 Collection Hemostasis Testing Methods optimize workflow with a strong mixture of high quality and effectivity, and connectivity throughout a whole laboratory community.
To streamline and optimize workflow, ACL Prime Household 70 Collection techniques provide centralized QC and automatic efficiency verification administration. When linked to HemoHub Clever Information Supervisor, synergistic integration permits uniform software of a laboratory’s High quality Administration System, throughout a number of devices and websites, from one centralized location; transcription errors are eradicated, and report era and storage automated. Efficiency verification research that beforehand concerned a number of guide processes are lowered to 2 automated steps, saving important workers time, enhancing high quality and decreasing prices.
References from Werfen
- Lippi G, Salvagno GL, Favaloro EJ, Guidi GC. Survey on the prevalence of hemolytic specimens in a tutorial hospital in accordance with assortment facility: alternatives for high quality enchancment. Clin Chem Lab Med. 2009;47(5):616–618. doi:10.1515/CCLM.2009.132.
- Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a serious problem for emergency departments and medical laboratories. Crit Rev Clin Lab Sci. 2011;48(3):143–153. doi:10.3109/10408363.2011.600228.
- O’Hara M, Wheatley EG, Kazmierczak SC. The influence of undetected in vitro hemolysis or pattern contamination on affected person care and outcomes in point-of-care testing: a retrospective research. J Appl Lab Med. 2020;5(2):332- 341. doi:10.1093/jalm/jfz020.
- Phelan MP, Ramos C, Walker LE, et al. The hidden price of hemolyzed blood samples within the emergency division. J Appl Lab Med. 2021;6(6):1607–1610. doi:10.1093/jalm/jfab035.
- Phelan MP, Hustey FM, Good DM, Reineks EZ. Seeing purple: blood pattern hemolysis is related to extended emergency division throughput. J Appl Lab Med. 2020;5(4):732–737. doi:10.1093/jalm/jfaa073.
- Wilson M, Adelman S, Maitre JB, et al. Accuracy of hemolyzed potassium ranges within the emergency division. West J Emerg Med. 2020;21(6):272–275. doi:10.5811/westjem.2020.8.46812.
- Milutinović D, Andrijević I, Ličina M, Andrijević L. Confidence stage in venipuncture and data on causes of in vitro hemolysis amongst healthcare professionals. Biochem Med. 2015;25(3):401–409. doi:10.11613/BM.2015.040.
